NASDAQ:IOVA - Iovance Biotherapeutics SEC Filings & 10K Form

Sign in or create an account to add this stock to your watchlist.
$11.00 -0.02 (-0.18 %)
(As of 04/26/2019 09:54 AM ET)
Previous Close$11.02
Today's Range$10.99 - $11.11
52-Week Range$7.26 - $18.25
Volume731 shs
Average Volume1.03 million shs
Market Capitalization$1.36 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.91

SEC Filings

Iovance Biotherapeutics (NASDAQ:IOVA) SEC Filings

DateFilerForm TypeView
04/19/2019
3:31 PM
Iovance Biotherapeutics (Filer)
Form PRE 14A
View Filing
03/06/2019
4:00 PM
Iovance Biotherapeutics (Issuer)
Vogt Frederick G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/06/2019
4:00 PM
Fardis Maria (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/06/2019
4:00 PM
Iovance Biotherapeutics (Issuer)
MORRIS TIMOTHY E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/14/2019
7:33 AM
Iovance Biotherapeutics (Subject)
venBio Select Advisor LLC (Filed by)
Form SC 13G/A
View Filing
01/28/2019
11:41 AM
FRANKLIN RESOURCES INC (Filed by)
Iovance Biotherapeutics (Subject)
Form SC 13G/A
View Filing
01/07/2019
7:30 AM
Iovance Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
12/20/2018
4:00 PM
Dukes Iain D. (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/14/2018
4:00 PM
Iovance Biotherapeutics (Issuer)
MCPEAK MERRILL A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/07/2018
3:34 PM
Iovance Biotherapeutics (Subject)
Quogue Capital LLC (Filed by)
Form SC 13D/A
View Filing
12/07/2018
3:32 PM
Iovance Biotherapeutics (Issuer)
Rothbaum Wayne P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
11/09/2018
4:16 PM
Iovance Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
11/06/2018
4:02 PM
Iovance Biotherapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
11/06/2018
3:05 PM
Iovance Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
10/25/2018
3:45 PM
Iovance Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
10/17/2018
6:02 AM
Iovance Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
10/12/2018
3:06 PM
Iovance Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
10/12/2018
3:04 PM
Iovance Biotherapeutics (Filer)
Form 424B5
View Filing
10/11/2018
8:35 PM
Iovance Biotherapeutics (Filer)
Form S-3MEF
View Filing
10/11/2018
3:11 PM
Iovance Biotherapeutics (Filer)
Form 424B5
View Filing
10/11/2018
3:03 PM
Iovance Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
10/03/2018
11:15 PM
Iovance Biotherapeutics (Filer)
Form EFFECT
View Filing
09/07/2018
4:21 PM
Iovance Biotherapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
View Filing
09/07/2018
4:17 PM
Iovance Biotherapeutics (Filer)
Form S-8 POS
View Filing
09/07/2018
4:13 PM
Iovance Biotherapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
View Filing
09/05/2018
7:30 AM
Iovance Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
08/07/2018
7:31 AM
Iovance Biotherapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
08/06/2018
3:05 PM
Iovance Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
07/19/2018
4:39 PM
Iovance Biotherapeutics (Issuer)
WEISER MICHAEL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
07/19/2018
4:30 PM
Iovance Biotherapeutics (Issuer)
MCPEAK MERRILL A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
07/19/2018
4:17 PM
Dukes Iain D. (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
07/19/2018
4:07 PM
Iovance Biotherapeutics (Issuer)
Maynard Ryan D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/08/2018
3:30 PM
Iovance Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
06/07/2018
7:30 AM
Iovance Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/09/2018
7:01 PM
Iovance Biotherapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
04/27/2018
5:20 AM
Iovance Biotherapeutics (Filer)
Form DEFA14A
View Filing
04/25/2018
4:01 PM
Iovance Biotherapeutics (Filer)
Form DEF 14A
View Filing
04/06/2018
4:27 PM
Iovance Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
03/19/2018
3:29 PM
Iovance Biotherapeutics (Issuer)
WEISER MICHAEL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/19/2018
3:21 PM
Iovance Biotherapeutics (Issuer)
WEISER MICHAEL (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
03/14/2018
3:36 PM
Iovance Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
03/12/2018
4:16 PM
Iovance Biotherapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
View Filing
03/01/2018
7:30 AM
Iovance Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
02/14/2018
2:00 PM
Iovance Biotherapeutics (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
Form SC 13G/A
View Filing
02/13/2018
3:43 PM
Iovance Biotherapeutics (Subject)
ORBIMED ADVISORS LLC (Filed by)
Form SC 13G/A
View Filing
02/13/2018
8:39 AM
FMR LLC (Filed by)
Iovance Biotherapeutics (Subject)
Form SC 13G/A
View Filing
02/12/2018
7:18 PM
Fardis Maria (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/12/2018
3:09 PM
Iovance Biotherapeutics (Subject)
venBio Select Advisor LLC (Filed by)
Form SC 13G/A
View Filing
02/07/2018
11:33 AM
FRANKLIN RESOURCES INC (Filed by)
Iovance Biotherapeutics (Subject)
Form SC 13G/A
View Filing
01/29/2018
3:10 PM
Iovance Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
01/25/2018
4:12 PM
Iovance Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
01/25/2018
3:17 PM
Iovance Biotherapeutics (Filer)
Form 424B5
View Filing
01/25/2018
10:13 AM
BlackRock Inc. (Filed by)
Iovance Biotherapeutics (Subject)
Form SC 13G
View Filing
01/24/2018
3:14 PM
Iovance Biotherapeutics (Filer)
Form 424B5
View Filing
01/24/2018
3:07 PM
Iovance Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
01/22/2018
11:15 PM
Iovance Biotherapeutics (Filer)
Form EFFECT
View Filing
01/09/2018
5:05 AM
Iovance Biotherapeutics (Filer)
Form 424B3
View Filing
01/08/2018
12:30 PM
Iovance Biotherapeutics (Issuer)
Vogt Frederick G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/08/2018
5:05 AM
Iovance Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
12/28/2017
4:17 PM
Iovance Biotherapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
View Filing
12/13/2017
7:00 AM
Iovance Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
12/01/2017
4:29 PM
Iovance Biotherapeutics (Filer)
Form 424B3
View Filing
This page was last updated on 4/26/2019 by MarketBeat.com Staff

Featured Article: Growth and Income Funds

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel